Consolidated Balance Sheets (USD $) In Thousands, unless otherwise specified	Jun. 30, 2013	Jun. 30, 2012
Current assets:
Cash	$ 55	$ 145
Accounts receivable, net	2,419	2,035
Inventories, net	6,431	5,290
Investment in iBio, Inc.	684	823
Other current assets	339	391
Total current assets	9,928	8,684
Intangible assets, net	1,017	1,154
Property and equipment, net	1,235	1,449
Security deposits and other assets	431	590
Total assets	12,611	11,877
Current liabilities:
Accounts payable (includes $186 and $72 due to a related party for 2013 and 2012)	5,883	6,481
Accrued expenses and other current liabilities	1,122	1,549
Current portion of long term debt	868	1,496
Total current liabilities	12,416	12,203
Long term debt	4,888	4,698
Subordinated convertible note, net - CD Financial, LLC	4,901	4,796
Derivative liabilities	696	563
Total liabilities	22,901	22,260
Commitments and contingencies
Stockholders' deficiency:
Common Stock, par value $0.002 per share; shares authorized 50,000,000; shares issued and outstanding were 21,115,074 and 21,080,174, respectivley	42	42
Additional paid-in-capital	44,568	44,568
Accumulated deficit	(54,801)	(54,894)
Less: Treasury stock, at cost, 34,900 shares	(99)	(99)
Total stockholders' deficiency	(10,290)	(10,383)
Total liabilities and stockholders' deficiency	12,611	11,877
Advances Under Credit Facility [Member]
Current liabilities:
Advances under revolving credit facility	$ 4,543	$ 2,677